Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

Emergency room visits attributed to popular weight loss drugs such as Ozempic and Wegovy remain quite rare overall, but do ...

As the obesity rate among people with type 1 diabetes rises, patients are taking popular weight loss drugs like Ozempic—and ...

Each Baqsimi device includes 1 dose of glucagon and cannot be refused. The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment ...

Primary care doctors can treat most patients with diabetes, but occasionally, you may want to call in a specialist. Here’s ...

Medicare Advantage plans are squeezing billions out of the federal government by billing more for patient care, a new study ...

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

Continuous glucose monitoring with low-glucose alerts shows potential for reducing hypoglycemia risk in insulin-treated ...

To the Editor: Although Nissan, Bar-Maor and Shafrir 1 present some interesting observations on the hypoglycemia of two terminal patients with lymphoma, several aspects of their interpretations ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

Amylyx Pharma (AMLX) stock was upgraded to Outperform at Mizuho citing its lead asset avexitide's potential against a rare ...